Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

FLGT – Fulgent Genetics, Inc.

Float Short %

9.34

Margin Of Safety %

Put/Call OI Ratio

0.14

EPS Next Q Diff

-0.25

EPS Last/This Y

1.69

EPS This/Next Y

-0.6

Price

27.79

Target Price

33.67

Analyst Recom

2

Performance Q

24.79

Relative Volume

0.78

Beta

0.62

Ticker: FLGT




18 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-10FLGT27.150.110.004488
2025-11-11FLGT28.40.120.014346
2025-11-12FLGT29.080.120.094454
2025-11-13FLGT29.610.110.034531
2025-11-14FLGT29.120.110.014618
2025-11-17FLGT28.830.101.264961
2025-11-18FLGT28.980.110.004992
2025-11-19FLGT28.980.110.095034
2025-11-20FLGT28.780.110.005028
2025-11-21FLGT29.980.110.084901
2025-11-24FLGT30.650.120.014116
2025-11-25FLGT30.840.120.044117
2025-11-26FLGT30.140.120.004208
2025-12-01FLGT28.520.140.084411
2025-12-02FLGT28.420.140.004409
2025-12-03FLGT28.490.144.004409
2025-12-04FLGT28.310.140.004406
2025-12-05FLGT27.910.140.604372
DateSymbolLatestP/C OIP/C VolTotal OI
18 items Current Page1 of 1




18 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-11-10FLGT27.16-657.20.0-0.35
2025-11-11FLGT28.38-657.2-0.7-0.35
2025-11-12FLGT29.09-657.221.7-0.35
2025-11-13FLGT29.61-657.222.10.30
2025-11-14FLGT29.1223.824.00.30
2025-11-17FLGT28.81-75.623.70.26
2025-11-18FLGT29.12-75.622.50.26
2025-11-19FLGT29.00-75.623.40.26
2025-11-20FLGT28.80-75.623.50.28
2025-11-21FLGT30.01-25.420.70.28
2025-11-24FLGT30.66-25.422.00.28
2025-11-25FLGT30.85-25.422.80.28
2025-11-26FLGT30.16-25.424.40.28
2025-12-01FLGT28.50-25.425.20.28
2025-12-02FLGT28.40-25.423.50.28
2025-12-03FLGT28.48-25.423.00.28
2025-12-04FLGT28.31-25.423.50.28
2025-12-05FLGT27.79-25.424.20.28
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
18 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-10FLGT-0.104.029.68
2025-11-11FLGT-0.104.029.68
2025-11-12FLGT-0.094.029.40
2025-11-13FLGT-0.094.029.40
2025-11-14FLGT-0.094.029.40
2025-11-17FLGT-0.0915.099.40
2025-11-18FLGT-0.0915.099.40
2025-11-19FLGT-0.0915.099.40
2025-11-20FLGT-0.0915.099.40
2025-11-21FLGT-0.1915.099.40
2025-11-24FLGT-0.195.439.40
2025-11-25FLGT-0.205.439.40
2025-11-26FLGT-0.205.439.35
2025-12-01FLGT-0.175.339.34
2025-12-02FLGT-0.195.339.34
2025-12-03FLGT-0.195.339.34
2025-12-04FLGT-0.195.339.34
2025-12-05FLGT-0.195.339.34
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS

0.14

Avg. EPS Est. Current Quarter

0.03

Avg. EPS Est. Next Quarter

-0.11

Insider Transactions

-0.19

Institutional Transactions

5.33

Beta

0.62

Average Sales Estimate Current Quarter

85

Average Sales Estimate Next Quarter

82

Fair Value

Quality Score

41

Growth Score

38

Sentiment Score

20

Actual DrawDown %

85.4

Max Drawdown 5-Year %

-91.7

Target Price

33.67

P/E

Forward P/E

PEG

P/S

2.72

P/B

0.76

P/Free Cash Flow

EPS

-1.4

Average EPS Est. Cur. Y​

0.28

EPS Next Y. (Est.)

-0.32

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-13.62

Relative Volume

0.78

Return on Equity vs Sector %

-30.7

Return on Equity vs Industry %

-14.6

EPS 1 7Days Diff

0.6

EPS 1 30Days Diff

0.63

EBIT Estimation

24.2
Fulgent Genetics, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 1313
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.
stock quote shares FLGT – Fulgent Genetics, Inc. Stock Price stock today
news today FLGT – Fulgent Genetics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch FLGT – Fulgent Genetics, Inc. yahoo finance google finance
stock history FLGT – Fulgent Genetics, Inc. invest stock market
stock prices FLGT premarket after hours
ticker FLGT fair value insiders trading